Pharmabiz2h
Immuneel Therapeutics launches Qartemi, India’s first global CAR T-cell therapy for non-Hodgkin’s lymphoma
Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST] ...
Pharmabiz2h
Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer
Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer: Thousand Oaks, California Monday, January 20 ...
Pharmabiz4h
TN IPA and IDMA to hold an international symposium on ‘Dissolution and Drug Development’ at MMC Chennai on January 23
TN IPA and IDMA to hold an international symposium on ‘Dissolution and Drug Development’ at MMC Chennai on January 23: Our Bureau, Chennai Monday, January 20, 2025, 12:15 Hrs ...
Pharmabiz3h
EMA recommends approval of Bluevac-3 and Syvazul BTV 3 vaccines to protect sheep against bluetongue disease
EMA recommends approval of Bluevac-3 and Syvazul BTV 3 vaccines to protect sheep against bluetongue disease: Amsterdam, The Netherlands Monday, January 20, 2025, 13:00 Hrs [IST] E ...
Pharmabiz1h
National Institutes of Health to lead implementation of National Plan to End Parkinson’s Act
National Institutes of Health to lead implementation of National Plan to End Parkinson’s Act: Bethesda, Maryland Monday, January 20, 2025, 15:00 Hrs [IST] With support from the ...
Pharmabiz5h
Fermion and Simcere Pharma ink partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4
Fermion and Simcere Pharma ink partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4: Guangzhou, China Monday, January 20, 2025, 11:00 Hrs [IST] ...
Pharmabiz7h
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma
AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma: Cambridge, UK Monday, January 20, 2025, 09:00 Hrs [IS ...
Pharmabiz4d
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome
Acadia Pharma seeks European marketing approval for trofinetide for the treatment of Rett syndrome: San Diego Thursday, January 16, 2025, 13:00 Hrs [IST] Acadia Pharmaceuticals In ...
Pharmabiz1d
Avicanna enters scientific and medical affairs collaboration with Vectura Fertin Pharma
Avicanna Inc., a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, announced that Avicanna has entered into a ...
Pharmabiz1d
WHO launches US$ 1.5 billion Health Emergency Appeal to tackle unprecedented global health crises
Conflict, climate change, epidemics, and displacement are converging to create an unparalleled global health crisis, with 305 million people in urgent need of humanitarian assistance in 2025. In ...
Pharmabiz2d
Laxxon Medical reports positive results from pilot PK study of innovative oral GLP-1 agonist weight loss tablet, LXM.2
Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, announced the successful results of its pilot nonclinical ...
Pharmabiz2d
Boehringer Ingelheim’s phase III CONNEX clinical programme of iclepertin in schizophrenia fails to meet primary and key secondary endpoints
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, announced top-line results from the phase III CONNEX clinical programme in cognitive impairment in adults with ...